UGA Researchers Break Ground on Flu Vaccine

Researchers at the University of Georgia and Sanofi Pasteur, a multinational pharmaceutical company announced today the development of a vaccine that protects against multiple strains of both seasonal and pandemic H1N1 influenza in mouse models.

Using a technique called Computationally Optimized Broadly Reactive Antigen, UGA researchers Donald Carter, Christopher Darby and Bradford Lefoley created nine prototype synthetic compound vaccines constructed using genetic sequences from multiple influenza virus strains.

Sanofi Pasteur and UGA researchers are set to present their data tomorrow, March 30, at the World Vaccine Congress located in Washington, D.C.

Tags:

You May Also Like

Low Safety Rates for UGA Students in Athens

Athens, GA-   A survey from Student Government Association rated off-campus safety 3 out ...

Pizza and Politics: UGA Republicans, Democrats Discuss Key Issues

Audience members chowed down on pizza, snacks and sodas during Pizza and Politics, a ...

UGA Faculty Hacked By Email Scam

Last week an email was sent out to UGA faculty letting them know that ...